Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DAVITA INC. Director's Dealing 2014

Dec 22, 2014

30643_dirs_2014-12-22_22af63c2-a669-4167-9944-6c5f99710f64.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2014-12-19

Reporting Person: Mildenberger Laura (Chief People Ofcr, Kidney Care)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-12-19 Common Stock M 2500 $31.70 Acquired 9234 Direct
2014-12-19 Common Stock F 1054 $75.20 Disposed 8180 Direct
2014-12-19 Common Stock S 1446 $75.50 Disposed 6734 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-12-19 Stock Appreciation Rights $31.70 M 2500 Disposed 2015-03-31 Common Stock (2500) Direct

Footnotes

F1: Stock Appreciation Rights, granted on 3/31/2010, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 25% on the first anniversary of the grant date, then 6.25% every three months thereafter.